Related Experiment Video
Updated: May 1, 2026

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review
1Department of Hematology, The 3rd Xiangya Hospital, Central South University, Changsha, Hunan Province, PR China.
Abstract:
High mobility group box 1 (HMGB1) is an evolutionarily conserved protein, and is constitutively expressed in virtually all types of cells. Infection and injury converge on common inflammatory responses that are mediated by HMGB1 secreted from immunologically activated immune cells or passively released from pathologically damaged cells. Herein we review the emerging molecular mechanisms underlying the regulation of pathogen-associated molecular patterns (PAMPs)-induced HMGB1 secretion, and summarize many HMGB1-targeting therapeutic strategies for the treatment of infection- and injury-elicited inflammatory diseases. It may well be possible to develop strategies that specifically attenuate damage-associated molecular patterns (DAMPs)-mediated inflammatory responses without compromising the PAMPs-mediated innate immunity for the clinical management of infection- and injury-elicited inflammatory diseases.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Modified-Release Drug Delivery Systems: Influencing Factors
DNA Helicases
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Regulated mRNA Transport
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...

